US › Healthcare

Apyx Medical Inc (APYX)

US · Healthcare · Medical Devices

$4.28+2.39%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$12.5M
Revenue YoY
+32.4%
Net profit
$-2.1M
Profit YoY
+49.2%
EPS
$-0.05
EPS estimate
$-0.11
Net margin
-16.9%

EPS came in at -0.05 against a street estimate of -0.11 — a beat of 54.5%.

Key statistics

Market cap
$172.7M
Forward P/E
72.5
P/B
13.49
Book value
$0.31
EPS (TTM)
$-0.22
52-week high
$5.08
52-week low
$1.70
50-day MA
$4.23
200-day MA
$3.82
Beta
1.37

Analyst view

Analysts rate Apyx Medical Inc a buy (1 buy, 2 hold, 0 sell out of 3) with an average price target of $6.60.

Shareholding

Insiders
13.61%
Institutions
51.19%

Largest institutional holders

FundStake
Nantahala Capital Management, LLC8.17%
Archon Capital Management LLC6.63%
Royce & Associates, LP6.20%
Vanguard Capital Management, LLC3.69%
AIGH Capital Management, LLC2.62%
Silverberg Bernstein Capital Management LLC2.47%
Essex Investment Management Company, LLC2.14%
Commonwealth Equity Services, LLC1.54%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Apyx Medical Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.